Intended Audience: Oncology providers, including physicians, NPs, PAs, nurses, and pharmacists working in federal and public healthcare settings
Join us for this interactive session as renowned experts address advances in novel and emerging therapies for breast cancer in federal and public health care settings.
This webinar features the latest evidence and insights on:
Associate ProfessorDepartment of Hematology and Medical OncologyAssociate ProfessorDepartment of Gynecology and ObstetricsEmory University School of MedicineAtlanta, GA
Associate Professor of MedicineDirector, Breast Oncology ProgramDivision of Hematology-OncologyDavid Geffen School of Medicine at UCLACo-Director, Santa Monica-UCLA Outpatient Oncology PracticeMedical Director, Jonsson Comprehensive Cancer Center Clinical Research UnitUCLA Medical CenterSanta Monica, CA
Adjunct Associate ProfessorDepartment of PharmacotherapyUniversity of Utah College of PharmacySalt Lake City, UT
Medical DirectorHumanaFort Lauderdale, FL
Director, Professional AffairsPharmacy Technician Certification BoardWashington, DC
Adult Nurse PractitionerCommunity Hospital Oncology PhysiciansIndianapolis, IN
PRIME® designates this Live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
PRIME® has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit. PAs should only claim credit commensurate with the extent of their participation.
PRIME Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 060815. This activity is approved for 1.0 contact hour (which includes 0 hour of pharmacology).
This Application-based activity has been approved for 1.0 contact hour (0.1 CEUs) by PRIME® for pharmacists. The Universal Activity Number for this activity is JA0007144-0000-21-201-L01-P . Pharmacy CE credits can be submitted to the NABP upon successful completion of the activity by providing your NABP ID & DOB, which must be submitted within 60 days of completion. Pharmacists with questions can contact NABP customer service ([email protected]).
PRIME® designates this activity for 1.0 contact hour.
The Commission for Case Manager Certification designates this educational activity for 1.0 contact hour for certified case managers. Credits for this program are pre-approved.
Instructions to access CME/CE credit options will be provided at the end of the program.
*PRIME® has identified, reviewed, and mitigated all conflicts of interest that speakers, authors, course directors, planners, peer reviewers, or relevant staff disclose prior to the delivery of any educational activity.
The following individuals have identified relevant financial relationships with commercial interests to disclose:
The following individuals have no relevant financial relationships with commercial interests to disclose:
All PRIME® staff participating in planning and content development have no relevant financial relationships with commercial interests to disclose.